Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120736 | 0.72 | CYP3A4 (0.38) | MAPK1HPGDTSHRHSD17B10CYP3A4 | |
| SCHEMBL11208097 | 0.72 | — | — | |
| SCHEMBL11216740 | 0.72 | — | — | |
| SCHEMBL29953089 | 0.70 | ALDH1A1 (0.36) | — | |
| SCHEMBL8147651 | 0.70 | — | — | |
| SCHEMBL10140877 | 0.69 | GAA (0.46) | MAPK1TSHRTP53CYP3A4 | |
| SCHEMBL29956924 | 0.69 | TP53 (0.48) | AHRMAPK1HPGDTSHRHSD17B10 | |
| SCHEMBL12552106 | 0.69 | TP53 (0.48) | AHRMAPK1HPGDTSHRHSD17B10 | |
| SCHEMBL29950528 | 0.69 | TP53 (0.48) | AHRMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL13303852 | 0.69 | AHR (0.35) | AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751985-B2 | Triptycene-based dianhydrides, polyimides, methods of making each, and methods of use | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2017-09-05 | — | — | US | disclosed |
| US-20160102177-A1 | TRIPTYCENE-BASED DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2016-04-14 | — | — | US | disclosed |
| US-20120081482-A1 | Phthalocyanines and Their Use in Ink-Jet Printing | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2012-04-05 | — | — | US | disclosed |
| US-7842682-B2 | Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof | L. Molteni & C. Dei Fratelli Alitti (IT) | 2010-11-30 | — | — | US | disclosed |
| US-20080009464-A9 | Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A. (IT) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120081482-A1 | Phthalocyanines and Their Use in Ink-Jet Printing | RB1, IDH1, CRY1 | AHR 97/4885MAPK1 126/4885FLT1 630/4885 |
| US-20160102177-A1 | TRIPTYCENE-BASED DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | BET1, TRPC1, NOD2 | AHR 196/4885MAPK1 4760/4885FLT1 1355/4885 |
| US-20080009464-A9 | Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof | PBRM1, BOD1L1, PCBP1 | AHR 675/4885MAPK1 241/4885FLT1 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.